AWHL
Aspira Women's Health Inc.
Key Financials
Operating Income
$-7913000
↑ 51.4%
Gross Profit
$5.9M
↑ 8.0%
Revenue
$343000
↓ 91.4%
Net Income
$-12780000
↑ 2.4%
EPS (Diluted)
$-0.37
↑ 60.2%
Total Assets
$5.5M
↓ 0.6%
Shareholders' Equity
$-6932000.00
↓ 170.5%
Total Liabilities
$12.4M
↑ 53.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-K | 4/1/2026 | View on SEC |
| NT 10-K | 4/1/2026 | View on SEC |
| 8-K/A | 3/25/2026 | View on SEC |
| 8-K | 1/30/2026 | View on SEC |
| 424B3 | 1/12/2026 | View on SEC |
| EFFECT | 1/9/2026 | View on SEC |
| CORRESP | 1/7/2026 | View on SEC |
| UPLOAD | 1/6/2026 | View on SEC |
| S-1 | 12/31/2025 | View on SEC |
| 8-K | 12/31/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | AWHL |
| Company Name | Aspira Women's Health Inc. |
| CIK | 926617 |
| Sector | In Vitro & In Vivo Diagnostic Substances |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2835 |
| SIC Description | In Vitro & In Vivo Diagnostic Substances |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 512-519-0400 |